Note: To Fix or Not to Fix: Copyright's Fixation Requirement and the Rights of Theoretical Collaborators
By Carrie Ryan Gallia. Full text here. Despite its typical responsiveness to technological advances, copyright law has not kept pace with the emergence of the director as the primary player in American theater, leaving the contributions of this essential, creative artist without recognition or protection. Because work must be original, authored, and fixed to warrant…
Continue ReadingNote: Tax Increment Financing: Public Use or Private Abuse?
By Alyson Tomme. Full text here. In cities across the country, tax increment financing has grown substantially as a tool to promote economic development. Also known as TIF, this public financing method designates an area as a TIF district and subsequently freezes the tax base at a given year’s level. Any tax revenue generated above that…
Continue ReadingNote: Increasing E-Quality in Rural America: U.S. Spectrum Policy and Adverse Possession
By Lindsey L. Tonsager. Full text here. The United States is undergoing a communications revolution. Analog services are replacing digital, and broadband and mobile telephones are replacing dial-up and line lines. Businesses, educational institutions, consumers, and the public safety community increasingly rely on cheaper, faster, and always-on communications services that allow them to transmit voice, video,…
Continue ReadingNote: Determining a Corporation's Principal Place of Business: A Uniform Approach to Diversity Jurisdiction
By Lindsey D. Saunders. Full text here. For purposes of federal diversity jurisdiction under 28 U.S.C. § 1332, a corporation is a citizen of both its state of incorporation and the state where it has its principal place of business. In adopting that provision, Congress provided very little guidance to the federal courts as to the method…
Continue ReadingNote: Embracing Equity: A New Remedy for Wrongful Health Insurance Denials
By E. Daniel Robinson. Full text here. Through benefit decisions, health insurance companies have the power to refuse treatment to insured persons. Individuals harmed by denials that are unjustified or violate the insurance contract may have no recourse. The federal Employee Retirment Income Secuirty Act (ERISA) governs all health insurance plans provided through employers. With ERISA,…
Continue ReadingNote: From Deference to Restraint: Using the Chevron Framework to Evaluate Presidential Signing Statements
By David C. Jenson. Full text here. Presidential signing statements are creeping into judicial opinions with increasing frequency, leading to a resurgence of interest in the issue and several attempts, by Congress and others, to limit the use of signing statements or to challenge their constitutionality. This Note contends that the paramount separation of powers concern…
Continue ReadingNote: Fruit of the Poison Tree: A First Amendment Analysis of the History and Character of Intelligent Design Education
By Todd R. Olin. Full text here. Since the famous Scopes Trial in 1925, religious groups have struggled to introduce into public school science education a theory of human origin predicated on a supernatural creator. The latest theory to challenge evolution is Intelligent Design. Although this theory makes no explicit reference to religion or God, it…
Continue ReadingNote, Pharmacist Refusals: Dispensing (With) Religious Accomodation Under Title VII
By Amy Bergquist. Full text here. Pharmacists with greater frequency are refusing to fill certain prescriptions on religious grounds. These employees contend that Title VII of the Civil Rights Act requires pharmacies to accommodate refusing pharmacists by allowing other pharmacists to fill objectionable prescriptions. Some employers embrace this view and accommodate refusing pharmacists by sending customers…
Continue ReadingNote: "Don't Read This If It's Not For You": The Legal Inadequacies of Modern Approaches to E-mail Privacy
By Joshua L. Colburn. Full text here. E-mail has become the cheap and reliable replacement for many forms of business and personal communication. Despite a lack of any significant advances in privacy laws or software, lawyers have surrendered their once vocal privacy concerns in favor of efficient communication. In an effort to minimize any remaining privacy…
Continue ReadingNote: Evaluating the Integraty of Biotechnology Research Tools: Merck v. Integra and the Scope of 35 U.S.C. § 271(e)(1)
By Michael R. Mischnick. Full text here. Patents are critical in the biotechnology and pharmaceutical sectors. However, patents have inhibited competition in certain instances. For example, until the 1980s, pioneer drug companies benefited from a de facto “patent term windfall” because generic manufacturers could not begin the regulatory approval process of their generics until after…
Continue Reading